The autophagy-enhancing drugs carbamazepine and rapamycin stimulate intracellular degradation of misfolded Z-AAT and decrease hepatic fibrosis in a mouse model of AATD-associated liver disease [142, 143]. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.